Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Lipid Panel Testing Market Poised To Hit $17.79 Billion By 2030 With A 9% CAGR
The lipid panel testing market has demonstrated robust growth in recent years. It is projected to increase from $11.61 billion in 2025 to $12.61 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.6%. The historical expansion of this market can be attributed to factors such as the increasing prevalence of cardiovascular diseases, the broadening of routine health screening programs, a growing awareness of cholesterol management, the adoption of automated laboratory diagnostics, and enhanced access to diagnostic services.
The lipid panel testing market is projected to experience substantial growth in the coming years. This market is anticipated to reach a valuation of $17.79 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.0%. Factors driving this expansion during the forecast period include an enhanced emphasis on preventive healthcare, a surge in demand for home diagnostics, the incorporation of digital health platforms, the increasing utilization of AI-assisted diagnostic interpretation, and broader population health screening initiatives. Key trends anticipated during this period encompass a greater uptake of point-of-care lipid testing, an increased reliance on automated lipid analyzers, a growing need for preventive cardiovascular screening, the proliferation of home-based lipid testing kits, and a heightened focus on early risk assessment.
Get A Free Sample Report With In-Depth Market Insights:
Lipid Panel Testing Market Demand Drivers Opening New Revenue Streams
The growing incidence of cardiovascular and diabetic diseases is anticipated to drive the expansion of the lipid panel testing market in the future. Cardiovascular diseases encompass a range of conditions affecting the heart and blood vessels, whereas diabetes is a long-term metabolic disorder marked by elevated blood sugar levels. Both ailments substantially contribute to lipid irregularities, making lipid testing crucial for prompt diagnosis, risk assessment, treatment strategizing, and ongoing observation. Lipid panel testing aids medical professionals in identifying dyslipidemia, directing therapeutic approaches, and lowering the likelihood of complications like heart attacks and strokes. For example, in September 2025, the American College of Cardiology (ACC), a US-based nonprofit medical association, reported that worldwide cardiovascular disease fatalities reached $ 0.0192 billion (19.2 million) in 2023. Consequently, the increasing burden of cardiovascular and diabetic conditions is propelling the growth of the lipid panel testing market.
Lipid Panel Testing Market Segment Landscape: Which Areas Lead Development?
The lipid panel testing market covered in this report is segmented –
1) By Product And Services: Devices, Kits, Services
2) By Prescription Mode: Prescription-Based Testing, OTC-Based Testing
3) By Application: Hyperlipidemia, Hypertriglyceridemia, Familial Hypercholesterolemia, Hypo-Lipoproteinemia, Tangier Disease, Atherosclerosis, Other Applications
4) By End User: Hospital, Specialty Clinics And Physician Offices, Pathology Laboratories, Diagnostic Clinics, Reference Laboratories, Academic And Research Institutes, Other End-Users
Subsegments:
1) By Devices: Automated Analyzers, Point-Of-Care Testing Devices, Spectrophotometers
2) By Kits: Test Kits For Cholesterol, HDL And LDL Kits, Triglyceride Test Kits
3) By Services: Laboratory Testing Services, Diagnostic Services, Health Screening Services
Lipid Panel Testing Market Trends Powering Strategic Industry Growth
Leading firms within the lipid panel testing market are concentrating their efforts on creating sophisticated solutions, including diagnostic assays based on Lp(a), with the goal of improving the evaluation of cardiovascular risk. An Lp(a)-based assay is a medical examination designed to quantify lipoprotein(a) levels in the blood, thereby allowing medical professionals to pinpoint individuals facing a heightened risk of cardiovascular conditions and offer customized treatment advice. For example, in May 2024, F. Hoffmann-La Roche AG, a biotechnology and diagnostics company based in Switzerland, introduced its Tina-quant Lp(a) RxDx assay, following its recognition with FDA Breakthrough Device Designation. This novel solution quantifies the concentration of Lp(a) molecules per liter in a patient’s bloodstream, providing a consistent and practical biomarker for assessing cardiovascular risk. Fully integrated into Roche’s current serum work area (SWA) systems and cobas® platforms, it empowers healthcare providers to make well-informed choices concerning Lp(a)-reducing therapies, thereby enhancing patient results and fostering precise cardiovascular care. This assay streamlines Lp(a) testing, boosts diagnostic precision, and facilitates the broader acceptance of personalized lipid management approaches.
Lipid Panel Testing Market Competitive Landscape: Which Companies Lead The Industry?
Major companies operating in the lipid panel testing market are Abbott Laboratories, Beckman Coulter Inc., F. Hoffmann-La Roche Ltd., Randox Laboratories Ltd., Thermo Fisher Scientific Inc., PTS Diagnostics, Quest Diagnostics Incorporated, Alere Inc., Boston Heart Diagnostics Corporation, Eurofins Scientific SE, Spark Diagnostics Pvt Ltd., Everlywell Inc., Horiba ABX SAS, Siemens Healthcare GmbH, Nova Biomedical Corporation, Bio-Rad Laboratories Inc., Danaher Corporation, DiaSorin S.p.A., EKF Diagnostics Holdings plc, Ortho Clinical Diagnostics LLC
View The Full Lipid Panel Testing Market Report:
Lipid Panel Testing Market Regional Breakdown: Where Is Demand Concentrated?
North America was the largest region in the lipid panel testing market in 2025. Asia-Pacific is expected to be the fastest growing region in the global lipid panel testing market during the forecast period. The regions covered in the lipid panel testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
